NPI | Name | Type | Address |
---|---|---|---|
PHARMD Denise Luks-golger |
Individual |
2800 Main St Bridgeport, CT |
|
PHARMD Jane Lee |
Individual |
55 Park St New Haven, CT |
|
PHARMD Danielle Brown |
Individual |
55 Park St New Haven, CT |
|
DR. Scott Bourret |
Individual |
6 Devine St North Haven, CT |
|
PHARMD Molly Laura Schiffer |
Individual |
55 Park St New Haven, CT |
|
DR. PHARM D Usama Abdelghany |
Individual |
20 York St New Haven, CT |
|
DR. PHARM.D. Annette Podgorski Hood |
Individual |
55 Park St New Haven, CT |
|
PHARMD Megan P Pereira |
Individual |
55 Park St New Haven, CT |
|
Leonora Novak |
Individual |
55 Park St New Haven, CT |
|
DR. PHARM.D. Hiba Ahmad |
Individual |
55 Park St New Haven, CT |
|
DR. PHARMD Michael T Szewczyk JR. |
Individual |
230 Waterford Pkwy S Waterford, CT |
|
Barbara Cmuchowski |
Individual |
35 Park St New Haven, CT |
|
MR. R.PH., BCOP Thomas Michael Ferencz |
Individual |
55 Park St New Haven, CT |
|
PHARMD Alexandra Igoumenos |
Individual |
55 Park St New Haven, CT |
|
DR. PHARMD Marc Daniel Iannaccone |
Individual |
1100 Sherman Ave Hamden, CT |
|
Andrew Kowalski |
Individual |
55 Park St New Haven, CT |
|
Sergio F Toni JR. |
Individual |
20 York St New Haven, CT |
|
DR. PHARMD Mark Wysocki |
Individual |
55 Park St New Haven, CT |
|
MRS. BS PHARM., BCOP Nancy Jane Beaulieu |
Individual |
19 Lunar Dr Woodbridge, CT |
|
BSPHARMACY Robert James Marussich |
Individual |
77 Lafayette Pl Ste 200 Greenwich, CT |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |